IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities (Q39125719)
Jump to navigation
Jump to search
scientific article published on 12 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities |
scientific article published on 12 July 2013 |
Statements
1 reference
IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities (English)
1 reference
Ying-Bo Li
1 reference
Zhong-Qing Wang
1 reference
Xu Yan
1 reference
Mei-Wan Chen
1 reference
Jiao-Lin Bao
1 reference
Guo-Sheng Wu
1 reference
Ze-Mei Ge
1 reference
De-Min Zhou
1 reference
Yi-Tao Wang
1 reference
Run-Tao Li
1 reference
12 July 2013
1 reference
1 reference
340
1 reference
1
1 reference
88-96
1 reference
Identifiers
1 reference
1 reference